Table 1.
Association between QKI expression and clinical parameters in patients with NSCLC.
| Clinical parameters | n | QKI expression | P-value | |
|---|---|---|---|---|
| Low | High | |||
| Age | ||||
| >60 | 51 | 39 | 12 | 0.805 |
| ≤60 | 43 | 31 | 12 | |
| Gender | ||||
| Male | 51 | 40 | 11 | 0.091 |
| Female | 43 | 40 | 3 | |
| Tumor invasion | ||||
| T1–T2 | 71 | 48 | 23 | 0.008* |
| T3–T4 | 23 | 22 | 1 | |
| Lymph node metastases | ||||
| N0 | 57 | 43 | 14 | 0.979 |
| N1–N3 | 37 | 27 | 10 | |
| Clinical stage | ||||
| I | 30 | 18 | 12 | 0.029* |
| II–IV | 64 | 52 | 12 | |
| Pathological stage | ||||
| Well and moderate | 65 | 50 | 15 | 0.416 |
| Poorly and not | 29 | 20 | 9 | |
*Statistically significant (P < 0.05).